Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.32 USD 3.39% Market Closed
Market Cap: 536.8m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Investor Relations

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Robert Barrow
CEO & Director
No Bio Available
Dr. Daniel Rollings Karlin M.A., M.D.
Chief Medical Officer
No Bio Available
Dr. Miriam Halperin Wernli B.A., M.A., M.B.A., MBA, Ph.D.
Executive President
No Bio Available
Dr. Scott M. Freeman M.D.
Co-Founder & Clinical Advisor
No Bio Available
Mr. Leonard Latchman
Co-founder
No Bio Available
Ms. Carrie F. Liao CPA, CGMA
VP & Chief Accounting Officer
No Bio Available
Mr. Mark R. Sullivan J.D.
Chief Legal Officer & Corporate Secretary
No Bio Available
Dr. Francois P. Lilienthal M.B.A., M.D.
Chief Commercial Officer
No Bio Available
Ms. Stephanie Fagan
Chief Corporate Affairs Officer
No Bio Available
Dr. Gregg Pratt Ph.D.
Chief Regulatory & Quality Assurance Officer
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
1166 Alberni Steet, Suite 1604
Contacts
+12122206633.0
mindmed.co
sparklesyt

See Also

Summary
MNMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
MNMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MNMD stock valuation using valuation multiples.
Wall Street Estimates
MNMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MNMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.